Swiss National Bank »

Crispr Therapeutics shares owned by Swiss National Bank

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Swiss National Bank from 13F filings

Historical chart of Swiss National Bank investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Swiss National Bank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Swiss National Bank

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.3M 149k 62.60
2023-09-30 $7.5M 165k 45.39
2023-06-30 $9.1M 163k 56.14
2023-03-31 $7.3M 161k 45.23
2022-12-31 $7.3M 179k 40.65
2022-09-30 $11M 175k 65.35
2022-06-30 $11M 173k 60.77
2022-03-31 $9.1M 145k 62.77
2021-12-31 $10M 134k 75.78
2021-09-30 $15M 134k 111.93
2021-06-30 $22M 133k 161.89
2021-03-31 $17M 135k 121.85
2020-12-31 $18M 119k 153.11
2020-09-30 $9.7M 116k 83.64
2020-06-30 $6.5M 88k 73.49
2020-03-31 $2.5M 58k 42.42
2019-12-31 $3.2M 52k 60.90
2019-09-30 $2.0M 50k 40.99
2019-06-30 $2.3M 49k 47.10
2019-03-31 $1.3M 38k 35.71
2018-12-31 $966k 34k 28.58
2018-09-30 $1.5M 34k 44.35
2018-06-30 $1.9M 33k 58.75